SmartTab Closes Equity Crowdfunding Round on StartEngine

By Sacha Heppell - May 02, 2022

SmartTab's Equity Crowdfunding Campaign on StartEngine is Officially Complete

Congratulations to everyone who invested during SmartTab's equity crowdfunding campaign on StartEngine. We want to thank you for your partnership and commitment to advancing drug delivery technology.

The entire SmartTab team would like to extend our utmost gratitude and thanks to each and every one of our valued investors, supporters, friends and family. We’re absolutely thrilled by what we’ve achieved, opening up investments to individual investors and raising a total of $177,726 from 97 investors. Thank you for all the support we’ve received—from phone calls, emails, and texts. We will stay in touch along the way as we target larger strategic funding and advance SmartTab technology. Look out for our monthly investor only email updates and quarterly webinars. 

We look back on all the milestones and progress we've made in the last quarter and beyond. We've come this far from concept to reality thanks to passionate investors like you. We appreciate each and every one of you for believing in us and joining  our journey to transform a significant patient need. This is the beginning of a new chapter for SmartTab as we now focus on forwarding our intellectual property, conversations with the FDA, pharmaceutical partnerships, completing InjectTab™ preclinical studies and raising large strategic funding to reach commercialization. This is a mission, we are doing this for patients and for humanity. Everyday we continue to make progress and now we accelerate our efforts to build the future of drug delivery together. 

✨ Lab Facility in Health Tech Innovation Center in Denver and Plans in Place for Expansion to Larger Manufacturing Facility

✨ InjectTab™ Gastric Environment Validation Process Completed

✨ Successful TargetTab™ Animal Study and InjectTab™ Preclinical Study Underway for Summer 2022

✨ Currently in Dialogue with FDA: Pre-Submission In-Progress

✨ Total of 3 Patents Issued, 5 Patents Pending - Most Recent Patent Issued Jan. 2022

✨ Successful Startup Health Festival @ ViVE Conference 

✨ SXSW Pitch Finalist,  CEO of SmartTab Recognized on Denver Business Journal

✨ Named Top 100 Digital Health Companies by Medical Futurist

✨ Completed PharmStars Accelerator to Advance Digital-Pharma Partnerships

We are excited for this next chapter of SmartTab as we take our efforts to the next level to move our technology through clinical studies and FDA process.  We are on the leading edge of discovery alongside the most talented individuals in the area of wireless technology and pharmaceutical drug delivery. Thank you to our entire team for their tireless work over the years since beginning this journey, and this equity crowdfunding capital raise is a validation of our progress and determination. We are well on our way to achieving our goal of building the future of drug delivery together for patients.

We appreciate each and every one of you for believing in us and joining our journey to bring this cutting-edge technology to every patient and evolve the experience of drug delivery to one that is deserving of the 21st century.



Explore Ingestible Technology

A new publication covering the latest on wireless ingestible pharmaceutical drug delivery technologies.

Read More